RICHTVXNEWS
Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?
CNBC · ENGLEWOOD CLIFFS — Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
- CODE
- RT-91EA79
- PUBLISHER
- CNBC
- TOPIC
- Business
- PUBLISHED
- 09 November 2026 · 13:27 UTC
- FIRST SEEN
- 09 November 2026 · 13:30 UTC
- ORIGINAL
- https://www.cnbc.com/2026/11/09/novonesis-glp1-weight-loss-drugs-supplements-probiotics.html
- SHA-256
- c470ad5ce0ba09e5f33df5d5965fdad8d3cf4c923d887e62e270c71cb8ce7b85
The fingerprint is the SHA-256 of the original link, the headline and the publication time joined by “|”. Anyone can recompute it to confirm the headline and link were not changed here.
Headline and short excerpt from CNBC, taken from its public news feed. The full story and its photos belong to CNBC — read it at the original. RICHTVX NEWS is an independent aggregator and is not affiliated with CNBC. Corrections: legal@richtvx.news.
More from CNBC
Weekend trading of Nvidia scandal shines light on new financial productsRT-ABC07F · BUSINESS
Why tech workers are flocking to NYCRT-975590 · BUSINESS
Nasdaq defies Nvidia impact as Huang faces espionage affair probeRT-3F9AB8 · BUSINESS